Affiliate disclosure: As an Amazon Associate, this site earns from qualifying purchases linked in this article.
Ready to buy? Check current prices on Amazon and compare deals before you decide.
Navigating menopause often involves exploring various approaches to manage symptoms that can impact daily life. While hormone therapy is a well-known option, many women seek or require non-hormonal menopause treatment options due to personal preference, specific health considerations, or medical contraindications[1][2].
This overview provides evidence-based information on a range of non-hormonal strategies that may help alleviate common menopause symptoms. It’s important to discuss any symptom concerns and potential management strategies with a healthcare professional to determine the most suitable path for individual needs.
Understanding Vasomotor Symptoms and Non-Hormonal Approaches
Vasomotor symptoms (VMS), commonly known as hot flashes and night sweats, are among the most frequently reported and bothersome symptoms during menopause[3][4]. For individuals unable or unwilling to use hormone therapy, several non-hormonal medications have shown effectiveness in reducing the frequency and severity of these symptoms [5].
Fezolinetant is a non-hormonal medication specifically designed to target the neurokinin 3 (NK3) receptor, which plays a role in regulating body temperature. Studies have indicated that fezolinetant can reduce moderate-to-severe VMS associated with menopause [6]. Other pharmacological options include certain antidepressants, such as selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), which can help manage VMS[5][7]. Gabapentin and clonidine are also recognized as non-hormonal options for VMS management[5][8].
Addressing Genitourinary Syndrome of Menopause (GSM)
Genitourinary Syndrome of Menopause (GSM) encompasses a collection of symptoms and signs affecting the vulva, vagina, and lower urinary tract, often including vaginal dryness, irritation, painful intercourse, and urinary urgency[9][2]. While local estrogen therapy is a highly effective option for GSM, non-hormonal approaches are also available.
Non-hormonal lubricants and vaginal moisturizers are often recommended as a first-line approach for managing vaginal dryness and discomfort during sexual activity[9][10]. These products can help improve tissue hydration and reduce friction. Ospemifene, a selective estrogen receptor modulator (SERM), is another oral non-hormonal option that can help improve symptoms of vaginal atrophy [5]. Additionally, vaginal dilators and physical therapy may be beneficial for some individuals experiencing GSM symptoms [9].
Managing Sleep Disturbances and Mood Changes
Sleep disturbances, including insomnia and fragmented sleep, are common during menopause and can be linked to VMS or other factors [3]. Non-hormonal strategies for improving sleep quality include cognitive behavioral therapy for insomnia (CBT-I), which is considered an effective intervention [5]. Lifestyle adjustments such as maintaining a consistent sleep schedule, creating a comfortable sleep environment, and avoiding caffeine and heavy meals before bedtime can also be helpful.
Mood changes, such as irritability, anxiety, and depressive symptoms, can also occur during the menopausal transition [3]. While these can be multifaceted, non-hormonal pharmacological options like SSRIs and SNRIs, which are also used for VMS, may help alleviate some mood symptoms[5][7]. Non-pharmacological approaches, including mindfulness-based stress reduction, exercise, and psychotherapy, can also play a supportive role in managing mood [5].
Before you buy: black cohosh and liver safety. Nature’s Way Black Cohosh Root contains black cohosh. Products labelled as black cohosh have been implicated in cases of clinically apparent acute liver injury, some of them severe enough to lead to emergency liver transplantation or death, and the National Institute of Diabetes and Digestive and Kidney Diseases maintains a dedicated LiverTox monograph covering those reports. Causality is contested rather than settled, and a structured review of the early cases concluded it was not established in any of them. What the sources agree on is the practical guidance: anyone with existing liver disease should avoid black cohosh, and anyone taking it should stop and seek medical care if jaundice, dark urine, unusual fatigue or right-sided abdominal pain develops. Our evidence review of black cohosh safety works through the case reports and the causality assessments.
Lifestyle and Behavioral Interventions
Beyond specific medications, lifestyle and behavioral interventions are important non-hormonal menopause treatment options that can contribute to overall well-being and symptom management [5]. Regular physical activity, for instance, has been associated with improvements in mood, sleep, and potentially VMS in some individuals [10].
Dietary considerations may also play a role. While the evidence for specific dietary interventions directly reducing VMS is mixed, a balanced diet rich in fruits, vegetables, and whole grains supports general health during menopause [10]. Stress management techniques, such as meditation, yoga, and deep breathing exercises, can help in managing symptoms like anxiety and sleep disturbances [10].
Considerations for Individuals with Specific Health Conditions
For women who have experienced certain health conditions, such as breast cancer, hormone therapy may not be an appropriate option for symptom management [1]. In these cases, non-hormonal menopause treatment options become particularly important. The same non-hormonal medications and lifestyle interventions discussed above for VMS, GSM, sleep, and mood can be valuable for this population[1][7].
Healthcare providers often work closely with these individuals to tailor a symptom management plan that prioritizes safety while addressing bothersome menopausal symptoms effectively [1].
References
- Managing menopause after cancer. Lancet (London, England), 2024
- Menopause-Biology, consequences, supportive care, and therapeutic options. Cell, 2023
- Management of Menopausal Symptoms: A Review. JAMA, 2023
- Menopause. Annals of internal medicine, 2021
- The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause (New York, N.Y.), 2023
- Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study. Lancet (London, England), 2023
- Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer. The Lancet. Oncology, 2021
- Hormone Therapy and Other Treatments for Symptoms of Menopause. American family physician, 2016
- The AUA/SUFU/AUGS Guideline on Genitourinary Syndrome of Menopause. The Journal of urology, 2025
- Alternative and non-hormonal treatments to symptoms of menopause. Best practice & research. Clinical obstetrics & gynaecology, 2022
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
